These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15590165)

  • 1. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.
    Wernicke AG; Valicenti R; Dieva K; Houser C; Pequignot E
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1357-63. PubMed ID: 15590165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.
    Selek U; Cheung R; Lii M; Allen P; Steadham RE; Vantreese TR; Little DJ; Rosen II; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1039-46. PubMed ID: 15234037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
    Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.
    Roach M; Winter K; Michalski JM; Cox JD; Purdy JA; Bosch W; Lin X; Shipley WS
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1351-6. PubMed ID: 15590164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment.
    Buyyounouski MK; Horwitz EM; Price RA; Hanlon AL; Uzzo RG; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):743-9. PubMed ID: 14967429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial.
    Wiegner EA; King CR
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):442-8. PubMed ID: 20137864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma.
    Brown MW; Brooks JP; Albert PS; Poggi MM
    Prostate Cancer Prostatic Dis; 2007; 10(2):189-93. PubMed ID: 17189954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?
    Macdonald AG; Keyes M; Kruk A; Duncan G; Moravan V; Morris WJ
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):155-63. PubMed ID: 16111584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.
    Merrick GS; Butler WM; Wallner KE; Lief JH; Anderson RL; Smeiles BJ; Galbreath RW; Benson ML
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1055-62. PubMed ID: 12419431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).
    Mangar SA; Sydes MR; Tucker HL; Coffey J; Sohaib SA; Gianolini S; Webb S; Khoo VS; ; Dearnaley DP
    Radiother Oncol; 2006 Sep; 80(3):355-62. PubMed ID: 16949694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial.
    van der Wielen GJ; Hoogeman MS; Dohle GR; van Putten WL; Incrocci L
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):795-800. PubMed ID: 18164862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erectile dysfunction after prostate three-dimensional conformal radiation therapy. Correlation with the dose to the penile bulb.
    Magli A; Giangreco M; Crespi M; Negri A; Ceschia T; De Giorgi G; Titone F; Parisi G; Fongione S
    Strahlenther Onkol; 2012 Nov; 188(11):997-1002. PubMed ID: 23053160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erectile function durability following permanent prostate brachytherapy.
    Taira AV; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Kurko BS; Anderson R; Lief JH
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):639-48. PubMed ID: 19303721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.
    Zapatero A; Valcárcel F; Calvo FA; Algás R; Béjar A; Maldonado J; Villá S
    J Clin Oncol; 2005 Sep; 23(27):6561-8. PubMed ID: 16170164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
    Solan AN; Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1468-74. PubMed ID: 18922652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
    Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile function after prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Kurko BS; Lief JH; Allen ZA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):437-47. PubMed ID: 15890585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors.
    Lee CM; Lee RJ; Handrahan DL; Sause WT
    Urology; 2005 Jan; 65(1):114-9. PubMed ID: 15667875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.